Ceruletide reduces postoperative intestinal paralysis. A double-blind placebo-controlled trial.
D000005:Abdomen / Q000601:surgery; D000328:Adult; D000368:Aged; D002108:Ceruletide / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007410:Intestinal Diseases / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010528:Peristalsis / Q000187:drug effects; D011183:Postoperative Complications; D011897:Random Allocation
D002108:Ceruletide